Biopol Chemicals Ltd
Incorporated in 2023, Biopol Chemicals Limited is engaged in the manufacturing and distribution of specialty chemicals categorized into silicones, emulsifiers, biochemicals, and polyelectrolytes.[1]
- Market Cap ₹ 56.2 Cr.
- Current Price ₹ 52.0
- High / Low ₹ 134 / 39.5
- Stock P/E 6.26
- Book Value ₹ 46.2
- Dividend Yield 0.00 %
- ROCE 34.1 %
- ROE 28.2 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 1.13 times its book value
- Company has a good return on equity (ROE) track record: 3 Years ROE 31.0%
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Part of Nifty SME Emerge
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| 25.42 | 49.22 | 81.14 | |
| 20.99 | 42.67 | 67.69 | |
| Operating Profit | 4.43 | 6.55 | 13.45 |
| OPM % | 17.43% | 13.31% | 16.58% |
| 0.00 | 0.00 | 0.23 | |
| Interest | 0.39 | 0.68 | 1.52 |
| Depreciation | 0.08 | 0.09 | 0.10 |
| Profit before tax | 3.96 | 5.78 | 12.06 |
| Tax % | 25.25% | 25.43% | 25.62% |
| 2.96 | 4.31 | 8.97 | |
| EPS in Rs | 3.74 | 5.45 | 8.30 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 65% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 108% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 31% |
| Last Year: | 28% |
Balance Sheet
Figures in Rs. Crores
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Equity Capital | 7.91 | 7.91 | 10.81 |
| Reserves | 1.29 | 5.68 | 39.12 |
| 3.58 | 7.68 | 8.46 | |
| 4.77 | 10.40 | 11.38 | |
| Total Liabilities | 17.55 | 31.67 | 69.77 |
| 0.21 | 0.25 | 14.36 | |
| CWIP | 0.06 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 |
| 17.28 | 31.42 | 55.41 | |
| Total Assets | 17.55 | 31.67 | 69.77 |
Cash Flows
Figures in Rs. Crores
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| -6.44 | -2.41 | -12.77 | |
| -0.64 | -0.02 | -14.53 | |
| 7.14 | 3.50 | 26.67 | |
| Net Cash Flow | 0.06 | 1.07 | -0.63 |
| Free Cash Flow | -6.53 | -2.43 | -26.97 |
| CFO/OP | -141% | -30% | -93% |
Ratios
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Debtor Days | 145.45 | 123.55 | 125.01 |
| Inventory Days | 121.21 | 106.99 | 113.43 |
| Days Payable | 77.90 | 77.91 | 37.25 |
| Cash Conversion Cycle | 188.76 | 152.63 | 201.19 |
| Working Capital Days | 127.36 | 94.99 | 178.86 |
| ROCE % | 37.94% | 34.09% |
Documents
Announcements
-
Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter
- Biopol Chemicals says Corporate Governance Report not applicable for Q2 and half year ended September 30, 2026.
-
Certificate under SEBI (Depositories and Participants) Regulations, 2018
- Submitted Regulation 74(5) certificate for quarter and half-year ended September 30, 2026.
-
Trading Window
- Trading window closes from October 1, 2026 until 48 hours after half-year results disclosure.
-
Shareholders meeting
- 3rd AGM voting results: all 4 resolutions passed on 22 Sept 2026, including financials, director reappointment and RPTs.
-
General Updates
- AGM regularised Sukhomoy Das as Independent Director for five years from June 11, 2026.
Business Profile[1]
Biopol Chemicals Limited is engaged in the manufacturing, trading and distribution of specialty chemicals. The company operates on a B2B model, supplying to institutional and industrial customers. Its offerings cater primarily to textiles, home care, agriculture and industrial chemical applications. Alongside products, the company also provides technical consultancy services related to chemical applications and formulations.